Mercury Laboratories share news, announcements and annual reports
BSE: 538964Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 2 Nov 2026. Previous close ₹790.00.
2 Nov: open ₹897.95, high ₹897.95, low ₹760.05
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹91 Cr2,954th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 21.90
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.57
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.46%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 10
Mercury Laboratories share news and announcements
423 announcements, routine notices left out, newest first. Page 2 of 9.
May 2025
14 May · Corporate action
14 May · Board meeting
8 May · Board meeting
Meeting on 14 May 2025: audited results, final dividend and annual general meeting
Apr 2025
29 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
16 Apr · Management
11 Apr · Change In Email Address Of RTA MUFG Intime India Pvt Ltd
Feb 2025
24 Feb · Management
5 Feb · Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
5 Feb · Board meeting
Meeting on 12 Feb 2025: quarterly results
Jan 2025
1 Jan · Intimation For Change In Name Of RTA Of The Company
Dec 2024
16 Dec · Communication To Shareholders-Form DPT-1 Circular Or Circular In The Form Of Advertisement Inviting Unsecured Fixed Deposits From Members
Nov 2024
15 Nov · Results
7 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results
Sep 2024
Aug 2024
Jul 2024
26 Jul · Board meeting
24 Jul · Corporate action
24 Jul · Management
24 Jul · Board meeting
18 Jul · Board meeting
Meeting on 24 Jul 2024: annual general meeting and quarterly results
Jun 2024
21 Jun · Announcement Under Reg 30(LODR)
May 2024
28 May · Dividend
28 May · Board meeting